Stem cells for behavior problems in Alzheimer's
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether a single infusion of human mesenchymal stem cells (hMSC) can improve difficult behaviors like agitation, anxiety, or hallucinations in people with Alzheimer's disease. It's designed for those who have been taking antipsychotic medication for at least 4 weeks and have a study partner to help track behavior changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 55 and 90 years old.
- You have a diagnosis of probable Alzheimer's disease with brain scan results that support it.
- You have had behavioral symptoms (like agitation, anxiety, delusions, or sleep problems) for at least 4 weeks.
- You have been taking an antipsychotic medication for at least 4 weeks before the stem cell infusion.
- You have a family member or friend (study partner) who can regularly answer questions about your behavior.
- You do not have other types of dementia, severe depression, recent substance abuse, bleeding disorders, HIV, hepatitis, or uncontrolled medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new stem cell treatment (called RB-ADSCs) that is injected into the fluid around your brain. It aims to see if these cells can help slow down memory loss and thinking problems in people with mild to moderate Alzheimer's disease.
This trial tests a new nasal drop treatment made from stem cells for people with Alzheimer's, Parkinson's, multiple system atrophy, Lewy body dementia, frontotemporal dementia, or ALS. The drops may help slow disease progression by delivering tiny healing particles directly to the brain through the nose.
This trial tests whether stem cells from donated fat tissue can help people with mild to moderate Alzheimer's disease. It combines infusions of these cells with standard care, and includes brain scans and memory tests to see if the treatment is safe and effective.
This Phase 1 study tests whether injecting your own (autologous) activated fat-derived stem cells into the brain is safe and potentially helpful for mild to moderate Alzheimer’s disease. The goal is to see how the treatment affects the brain and symptoms, using cells made from your own donated fat tissue.
This trial tests an investigational drug called BMS-986368 to see if it can safely reduce agitation in people with Alzheimer's disease. You may be able to join if you have Alzheimer's with confirmed biomarkers and experience agitation that has been going on for at least 4 weeks.
This Phase 2 study tests whether sargramostim (a GM-CSF related medicine) is safe and can slow or improve Alzheimer’s symptoms. You might be a good fit if you have mild or moderate Alzheimer’s, positive amyloid testing, and can complete frequent visits with a close caregiver who knows you well.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.